Cell-Based Therapy for Neural Disorders - Anticipating Challenges

被引:34
|
作者
Chiu, Arlene Y. [1 ]
Rao, Mahendra S. [2 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA
[2] Life Technol Corp, Carlsbad, CA USA
关键词
Pluripotent stem cells; ESC; CNS roadblocks; EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; DIRECT CONVERSION; FIBROBLASTS; PLASTICITY; MUTATION; NEURONS; INJURY; CNS;
D O I
10.1007/s13311-011-0066-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurological syndromes, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and lysosomal storage disorders, such as Battens disease, are devastating because they result in increasing loss of cognitive and physical function. Sadly, no drugs are currently available to halt their progression. The relative paucity of curative approaches for these and other conditions of the nervous system have led to a widespread evaluation of alternative treatment modalities including cell-based interventions. Several cell types have been tested successfully in animal models where safety and efficacy have been demonstrated. Early clinical trials have also been initiated in humans, and some have shown a degree of success albeit on a more limited scale than in animal experiments. Recent demonstrations that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, can differentiate into a variety of specific neural phenotypes has stimulated worldwide enthusiasm for developing cell-based intervention of neurological disease. Indeed, several groups are preparing investigational new drug applications to treat disorders as diverse as macular degeneration, lysosomal storage diseases, and Parkinson's disease. It is noteworthy that cell replacement therapies for neurological conditions face key challenges, some of which are unique, because of the development and organization of the nervous system, its metabolism, and connectivity. Choice of the cell (or cells), the process of manufacturing them, defining the delivery pathway, developing and testing in an appropriate preclinical model, selecting a patient population, and visualizing and following or monitoring patients all pose specific issues as related to the central and peripheral nervous systems. In this review, we address a myriad of challenges that are solvable, but require careful planning and attention to the special demands of the human nervous system.
引用
收藏
页码:744 / 752
页数:9
相关论文
共 50 条
  • [11] Hope and Challenges for Dendritic Cell-Based Vaccine Therapy for Glioblastoma
    Nakano, Ichiro
    Chiocca, E. Antonio
    WORLD NEUROSURGERY, 2012, 77 (5-6) : 633 - 635
  • [12] Cell-based therapy for diabetic cardiovascular complications: Prospects and challenges
    Li, Jia-Peng
    Fu, Meng-Meng
    Li, Xiao-Xue
    Xu, Ming
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [13] Stem Cell-Based Therapy for Asherman Syndrome: Promises and Challenges
    Gao, Yiyin
    Wu, Guijie
    Xu, Ying
    Zhao, Donghai
    Zheng, Lianwen
    CELL TRANSPLANTATION, 2021, 30
  • [14] Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges
    Najar, Mehdi
    Bouhtit, Fatima
    Melki, Rahma
    Afif, Hassan
    Hamal, Abdellah
    Fahmi, Hassan
    Merimi, Makram
    Lagneaux, Laurence
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [15] Pluripotent Stem Cell-Based Cancer Therapy: Promise and Challenges
    Sharkis, Saul J.
    Jones, Richard J.
    Civin, Curt
    Jang, Yoon-Young
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (127)
  • [16] Challenges and Prospects for Stem Cell-Based Therapy in Diabetes Mellitus
    Assady, Suheir
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (04): : 212 - 215
  • [17] Stem Cell-Based and Gene Therapy for Hereditary Muscle Disorders
    Chuah, Marinee K.
    CURRENT GENE THERAPY, 2015, 15 (04) : 327 - 328
  • [18] Neural Stem Cell-based Gene Therapy for Brain Tumors
    Kim, Seung U.
    STEM CELL REVIEWS AND REPORTS, 2011, 7 (01) : 130 - 140
  • [19] Human Neural Stem Cell-Based Therapy for Canavan Disease
    Leone, Paola
    Markov, Vladimir
    Uchida, Nobuko
    Francis, Jeremy S.
    MOLECULAR THERAPY, 2014, 22 : S280 - S281
  • [20] Neural Stem Cell-based Gene Therapy for Brain Tumors
    Seung U. Kim
    Stem Cell Reviews and Reports, 2011, 7 : 130 - 140